Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC
Weiran Liu(Tianjin Medical University Cancer Institute and Hospital), Bin Zhang(Icahn School of Medicine at Mount Sinai)
Cited by 38